Validation of Prevalence and Incidence Rates for Six Different Diseases Using Livingstone: An Online, Automated Analytical Platform
Author(s)
Heywood B1, Jones B1, Morgan C1, Thomason R1, Currie C2
1Human Data Sciences, Cardiff, Wales, CRF, UK, 2Cardiff University, Cardiff, UK
Presentation Documents
OBJECTIVES:
Livingstone is a trusted research environment that allows the user to define cohorts from real-world data and output reproducible epidemiology reports. Incidence and prevalence are key epidemiological metrics that may vary by case definition, the acute or chronic nature of the disease, and denominator selection. In this study, we compared incidence and prevalence estimates derived automatically from Livingstone with published data.METHODS:
RESULTS:
For the overall annual estimates, the CCC for incidence was 0.97 (95% CI 0.97–0.98) and 0.99 (0.99–0.99) for prevalence. For each condition by year, the CCCs for incidence were: Charcot-Marie tooth disease 0.61 (0.27–0.82); Guillain-Barre syndrome 0.80 (0.58–0.91); inflammatory myopathy 0.86 (0.70–0.94); MND 0.52 (0.25–0.72); MD 0.78 (0.56–0.89), and myasthenia gravis 0.89 (0.75–0.95). For prevalence, the corresponding CCCs were 0.96 (95% CI 0.92–0.98); 1.00 (0.99–1.00); 0.95 (0.89–0.98); 0.20 (0.02–0.37); 0.24 (0.08–0.38); and 0.97 (0.94–0.99), respectively.CONCLUSIONS:
Conference/Value in Health Info
Value in Health, Volume 25, Issue 12S (December 2022)
Code
RWD77
Topic
Epidemiology & Public Health
Disease
No Additional Disease & Conditions/Specialized Treatment Areas